Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Major step forward in thermally-stable TB vaccines
The findings, published in Scientific Reports, were described by researchers as a big step forward.
Promising vaccine can be protected from heat damage - study

A promising TB vaccine for cattle and humans can be protected from heat damage, using a new technique developed at the University of Bath, scientists say.

The new method, called ensilication, prevents crucial vaccine components spoiling outside the fridge by ‘shrink wrapping’ the proteins in position, using layers of silica that build a ‘cage’ around the molecules.

Researchers showed that the TB antigen ag85b and a vaccine fused with the adjuvant protein Sbi, are sensitive to breakdown outside of the fridge.

They were then able to show for the first time that these vaccine components were protected from heat damage when ensilicated and kept at room temperature for long periods of time.

The findings, published in Scientific Reports, were described by researchers as a big step forward, not only in developing thermally-stable TB vaccines, but also in showing that this technique could be used for many different kinds of vaccine.

Fifty per cent of vaccines are currently discarded before use, after exposure to suboptimal temperatures. The World Health Organisation named thermostable vaccines a priority research area in its Global Vaccine Action Plan for 2011-2020.

Lead author Professor Jean van den Elsen said: “A new TB vaccine is really urgently needed to supplement or replace the existing BCG vaccine and reduce the number of TB cases and deaths – particularly as drug-resistant TB infections remain high.”

First author Ayla Wahid, added: “To make the vaccine as effective as possible it needs to be thermally-stable, or in other words not spoil outside of a fridge, which is why we’re really encouraged by these results. Cold-chain storage leads to a lot of wastage and expense which could be avoided by ensilication.”

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
BSAVA announces 12th Edition of the Small Animal Formulary

The BSAVA has published an updated edition of its Small Animal Formulary, which includes new drug monographs and emergency drug doses for rabbits, rodents, birds and reptiles.

One of BSAVA's most trusted and widely used clinical resources, this 12th edition of the manual also includes seven new client information leaflets and information on drugs used for the management of urinary incontinence.

Part A of the Formulary, Canine and Feline, sees Fergus Allerton return as Editor-in-Chief, while Part B: Exotic Pets was edited by Joanna Hedley. For more information, visit the BSAVA website.